Literature DB >> 33499800

Docosahexaenoic fatty acid reduces the pro-inflammatory response induced by IL-1β in astrocytes through inhibition of NF-κB and AP-1 transcription factor activation.

Emilia Zgórzyńska1, Dawid Stulczewski2, Barbara Dziedzic2, Kuan-Pin Su3,4,5, Anna Walczewska2.   

Abstract

BACKGROUND: Astrocytes are responsible for a broad range of functions that maintain homeostasis in the brain. However, their response to the pro-inflammatory cytokines released by activated microglia in various neurological pathologies may exacerbate neurodegenerative processes. Accumulating evidence suggests that omega-3 docosahexaenoic fatty acid (DHA) has an anti-inflammatory effect in various cell cultures studies and in a variety of neurological disorders. In this study we examined the mechanism involved in the inhibition of the pro-inflammatory response by DHA in astrocytes treated with IL-1β. METHODS AND
RESULTS: Activation of the transcription factors NF-κB and AP-1 was measured in IL-1β-treated primary astrocytes incubated with various concentrations of DHA. COX-2 and iNOS protein expression was determined by Western blot, and TNF-α and IL-6 secretion was measured using ELISA-based assays. DHA treatment inhibited translocation of p65NF-κB to the nucleus, significantly lowered p65NF-κB protein level and fluorescence of p65NF-κB in the nucleus, reduced dose-dependently IκB protein phosphorylation, and the binding of the AP-1 transcription factor members (c-Jun/c-Fos) to the specific TPA-response element (TRE) of DNA. In addition, the expression of pro-inflammatory COX-2 and iNOS proteins was downregulated and TNF-α and IL-6 secretion was also reduced.
CONCLUSIONS: These results indicate that DHA is a powerful factor that reduces the pro-inflammatory response in astrocytes. Consequently, successful introduction of DHA into the astrocyte membranes can attenuate neuroinflammation, which is a key factor of age-related neurodegenerative disorders.

Entities:  

Keywords:  Astrocytes; Docosahexaenoic acid; Neuroinflammation

Mesh:

Substances:

Year:  2021        PMID: 33499800      PMCID: PMC7839194          DOI: 10.1186/s12868-021-00611-w

Source DB:  PubMed          Journal:  BMC Neurosci        ISSN: 1471-2202            Impact factor:   3.288


  37 in total

1.  Oxidative stress activates transcription factor NF-kB-mediated protective signaling in primary rat neuronal cultures.

Authors:  Ella Kratsovnik; Yael Bromberg; Oded Sperling; Esther Zoref-Shani
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

Review 2.  Chronic microglial activation and progressive dopaminergic neurotoxicity.

Authors:  M L Block; J-S Hong
Journal:  Biochem Soc Trans       Date:  2007-11       Impact factor: 5.407

3.  Characterisation of gamma-glutamylcysteine synthetase-heavy subunit promoter: a critical role for AP-1.

Authors:  I Rahman; C A Smith; F Antonicelli; W MacNee
Journal:  FEBS Lett       Date:  1998-05-01       Impact factor: 4.124

Review 4.  Docosahexaenoic acid affects cell signaling by altering lipid rafts.

Authors:  William Stillwell; Saame Raza Shaikh; Mustafa Zerouga; Rafat Siddiqui; Stephen R Wassall
Journal:  Reprod Nutr Dev       Date:  2005 Sep-Oct

5.  Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP.

Authors:  K Yeung; T Seitz; S Li; P Janosch; B McFerran; C Kaiser; F Fee; K D Katsanakis; D W Rose; H Mischak; J M Sedivy; W Kolch
Journal:  Nature       Date:  1999-09-09       Impact factor: 49.962

6.  Docosahexaenoic acid reduces amyloid-β(1-42) secretion in human AβPP-transfected CHO-cells by mechanisms other than inflammation related to PGE₂.

Authors:  Martijn C de Wilde; Eline M van der Beek; Amanda J Kiliaan; Inge Leenders; Almar A M Kuipers; Patrick J Kamphuis; Laus M Broersen
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

7.  Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation.

Authors:  K C Yeung; D W Rose; A S Dhillon; D Yaros; M Gustafsson; D Chatterjee; B McFerran; J Wyche; W Kolch; J M Sedivy
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

8.  Effects of n-3 FA supplementation on the release of proresolving lipid mediators by blood mononuclear cells: the OmegAD study.

Authors:  Xiuzhe Wang; Erik Hjorth; Inger Vedin; Maria Eriksdotter; Yvonne Freund-Levi; Lars-Olof Wahlund; Tommy Cederholm; Jan Palmblad; Marianne Schultzberg
Journal:  J Lipid Res       Date:  2015-01-23       Impact factor: 5.922

9.  Substrate preference in phosphatidylserine biosynthesis for docosahexaenoic acid containing species.

Authors:  Hee-Yong Kim; James Bigelow; Jillonne H Kevala
Journal:  Biochemistry       Date:  2004-02-03       Impact factor: 3.162

Review 10.  IL-1 Receptor-Associated Kinase Signaling and Its Role in Inflammation, Cancer Progression, and Therapy Resistance.

Authors:  Ajay Jain; Sabina Kaczanowska; Eduardo Davila
Journal:  Front Immunol       Date:  2014-11-17       Impact factor: 7.561

View more
  1 in total

1.  A Dichotomous Role for FABP7 in Sleep and Alzheimer's Disease Pathogenesis: A Hypothesis.

Authors:  Hope Needham; Grace Torpey; Carlos C Flores; Christopher J Davis; William M Vanderheyden; Jason R Gerstner
Journal:  Front Neurosci       Date:  2022-06-30       Impact factor: 5.152

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.